The contents of drug advertisements must be true and legal, and shall not contain false or exaggerated contents.
Advertisers who publish drug advertisements must check the approval number of drug advertisements and verify the approved contents, and may not publish drug advertisements that have not obtained the approval number or are inconsistent with the approved contents.
Twenty-ninth social organizations or other organizations and individuals who recommend drugs to the public in false advertisements and harm the legitimate rights and interests of the public shall bear joint liability according to law.
Thirtieth enterprises in the province to publish drug advertisements, shall be approved by the provincial drug supervision and administration department, and obtain the approval number of drug advertisements; If the drug advertisement has been approved by the drug supervision and administration department of other provinces in this province, it shall be reported to the drug supervision and administration department of this province for the record before the release.
The provincial drug supervision and administration department shall publish the contents of drug advertisements that have been approved or filed for the convenience of the public and relevant departments.
Advertisers shall report to the drug supervision and administration department and the administrative department for industry and commerce for the record before releasing drug advertisements.
Article 31 The drug supervision and administration department at or above the county level shall monitor the drug advertisements within its administrative area, and notify the administrative department for industry and commerce at the same level and the competent department of the advertisement publisher of the illegal drug advertisements that have not obtained the approval number or are inconsistent with the approved contents, and put forward suggestions for handling them; The administrative department for industry and commerce and the competent department of the advertisement publisher shall handle the matter according to law, and report the result in writing to the drug supervision and administration department within 5 days.
The administrative department for industry and commerce and the pharmaceutical supervisory and administrative department shall establish an announcement system, and issue a warning announcement to the society in time for illegal drug advertisements and drugs involved. Newspapers, radio, television, websites and other media shall publish and broadcast early warning announcements in a timely and free manner.
The competent department of advertisement publishers shall supervise and manage advertisement publishers to prevent and stop the publication of illegal drug advertisements.
Thirty-second non-pharmaceutical advertisements such as food and health care products shall not contain advertisements involving drugs.
Medical advertisements or advertisements for medical care consulting services shall not contain the contents of promoting drugs and preparations of medical institutions.
Article 33 pharmaceutical production and marketing enterprises and users shall abide by the provisions of the competent pricing department on drug price management, and shall not raise drug prices in any form without authorization.
Pharmaceutical production enterprises and users shall truthfully provide production and operation costs, actual purchase and sale prices, purchase and sale quantities and other relevant information. Declare the prices of its drugs and preparations to the competent price department as required.
It is forbidden to falsify costs, price fraud, profiteering and other acts that harm the interests of users.
Article 34 Drug retail enterprises and users shall mark and announce the retail price of drugs in a prominent position with the generic name of drugs, the name of patented drugs with new active compounds and the name of compound preparations, and provide inquiry services.
Article 35 When determining the price of drugs, the competent pricing department shall know the situation through expert argumentation, evaluation and investigation, and listen to opinions from all sides.
The competent pricing department shall regularly publish drug prices in the designated media, subject to the generic name of the drug, the name of the patented drug of the new active compound and the name of the compound preparation.
The competent pricing department shall strengthen the supervision and inspection of drug prices of drug production and trading enterprises and users, effectively curb false pricing and illegal price increases, promptly investigate and deal with price violations, and announce the investigation results to the public.